MARC

19/08/2025

MARC is delighted to announce the signing of a Memorandum of Understanding (MoU) with the First Riyadh Health Cluster (R1 Cluster).

As part of this collaboration, we are proud to launch the first workshop in Clinical Trial Project Management, scheduled for September 2025, and accredited by the Saudi Commission for Health Specialties (SCFHS).

This milestone marks the beginning of a fruitful partnership aimed at advancing clinical research capacity and professional training in Saudi Arabia.

17/08/2025

17/08/2025

MARC Center was honored to host a distinguished delegation from Horus University, led by Prof. Dr. Magda Nasr, Vice president of Horus University In Egypt- Egypt & Dean of the Faculty of Pharmacy, and presence of Prof. Dr. Abdelaziz Elgaml, Vice Dean of the faculty of Pharmacy for Postgraduate Studies and Research, Assist prof. Dr. Mahmoud Elkhodary, Assistant professor,Department of Pharmaceutical Chemistry & Head of Digital Transformation Unit, Dr. Eman H. Yousef, Ph.D , Lecturer Department of Pharmacology & Biochemistry Vice Director of Quality Assurance Unit, Dr. Mohamed El-Gamal, Lecturer, Department of Pharmacology &Biochemistry, and Dr. Mostafa Bahaa El-Din Lecturer, Department of Clinical Pharmacy.

The visit marked an important milestone with the signing of a Memorandum of Understanding (MoU) between Horus University and the MARC Center. This agreement establishes a framework for collaboration in clinical research, innovation, and professional development, fostering stronger ties between academia and research institutions.

As part of the visit, Prof. Magda Nasr Ahmed presented the Horus University Trophy to Dr. George M. Ragheb , CEO of the MARC Center, in recognition of this new partnership and as a token of appreciation.

Our esteemed guests then had a guided tour of our facilities MARC’s facilities. They expressed great admiration for the cutting-edge technology, advanced equipment, and world-class infrastructure that empower MARC to deliver excellence in clinical research and trials.

This collaboration reflects our shared vision of advancing scientific innovation and contributing to the development of healthcare and pharmaceutical research in the region. We look forward to a productive and impactful partnership with Horus University.

We were also delighted to welcome Hossam Al-Sharawy, a student from Horus University, who has officially joined the MARC Internship Program.

16/08/2025

MARC @ Evergreen 2025

Since 1975, the “Biennial Evergreen Phage Meeting” has been held every other year at the Evergreen State College campus (Olympia, WA, USA). The Evergreen Phage Meeting is an international forum for scientists, physicians, patients, and patient advocates from around the world to share the latest findings and trends in phage research and phage therapy. This year, the 26th edition of the meeting was hosted by the University of Tennessee, Knoxville USA.
MARC was present at the 26th Evergreen meeting in multiple capacities. First, Prof. Ramy K. Aziz Aziz, Head of MARC Biolabs and a long-standing meeting attendee (since 2009), organized and presented a pre-meeting workshop on ‘Phage Annotation and Genomics,’ in collaboration with the BV-BRC team, represented by Dr. Rebecca Wattam. Dr. Maher Zaki, Microbiology Scientist at MARC, participated in the workshop as well, through an online presentation on special genes within phage genomes.
Ms. Zainab Hammouda, bioinformatician at , had a poster in the meeting, which reflects collaborative work between Zewail City of Science and Technology City, Cairo University, and MARC.

Finally, MARC was a co-sponsor of the meeting, supporting students and junior scientists in the form of monetary awards. MARC and PHAGEBIOTICS RESEARCH FOUNDATION offered two awards for the best postdoctoral and student speakers, and three awards for the best posters.



Biology





hashtag
hashtag

05/08/2025

As part of MARC's commitment to quality and patient-centered care, we supported Pharmed Limited in completing the regulatory registration of Otomed Otic Drops with the Saudi Food and Drug Authority (SFDA).

At MARC Biolabs, our ISO 17025-accredited laboratories conducted the necessary testing, including bio-compatibility studies, which are essential for the registration of medical devices.

This specialized service continues to support companies working toward timely and reliable market approvals, both regionally and internationally.
We extend our appreciation to Dr. Heba Munir Affairs Manager at Pharmed HealthCare, for the successful registration.

For more information on our regulatory and testing services, reach out to our team at info.research@marc-eg.org

04/08/2025

Under the patronage of
Prof. Essam ELKORDI President of Alamein International University (AIU)
Prof. Hesham Gaber – Vice President for Academic Affairs
Prof. Khadija Ismail – Dean of the Faculty of Pharmacy
Prof. Alaa Abouelfotouh – Professor of Microbiology and Immunology and PharmD Program Director
We were honored to participate in an inspiring online session organized by Alamein International University, titled:
🎓 "MARC as a Unique Center for Bridging the Gap Between Academia and Industry"
🗓️ Tuesday, 29 July 2025

The session featured our distinguished team:
🔹 Dr. George M. Ragheb – CEO of MARC, who presented MARC as an integrated research organization and discussed how it supports the research environment in Egypt and beyond
🔹 Dr. Ramy K. Aziz – Head of MARC Bio-science Research Laboratories, who delivered a scientific talk highlighting MARC's advanced research capabilities and translational science efforts to bridge the gap between science and medical practice
🔹 Dr. Walaaeldin Ahmed – Business Development Manager at MARC, who shared valuable tips on career opportunities for graduates in the pharmaceutical and healthcare industries

In alignment with MARC’s commitment to fostering innovation and supporting the next generation of researchers, we are pleased to welcome a select group of Pharmacy students from AIU to join our internship program. This hands-on experience will equip them with practical skills and exposure to the real-world dynamics of scientific research and industry collaboration.

The meeting received great feedback from students, graduates, and faculty members, and laid the foundation for future collaboration between AIU and MARC.

31/07/2025

🎉 Congratulations, Prof. Ramy Aziz! 🇪🇬🌍

We are proud to share the exciting news that Prof. Ramy K. Aziz , Head of the Bioscience Research Lab division at MARC Center, has been selected to represent Egypt on the UNESCO Basic Sciences Advisory Board!

This global recognition reflects not only Prof. Ramy’s outstanding scientific contributions but also his dedication to advancing bioscience research and education in Egypt and beyond.

Being appointed to serve alongside world-renowned scientists—including Prof. Rino Rappuoli, the pioneer of reverse vaccinology—is a true honor and a testament to Prof. Ramy’s impact on the international scientific community.

From Dr. George M. Ragheb, senior management and all of us at MARC we extend our heartfelt congratulations on this well-deserved achievement. We’re always aligned and having shared vision in fulfilling unmet medical needs and serves for a better future and happier healthy lives

🔗 Learn more about the UNESCO Basic Sciences Program:
https://lnkd.in/dc8WTbNk

21/07/2025

State-of-the-Art Clinical Trial Unit – Advancing Research & Patient Care

We’re proud to introduce our Clinical Research Site, designed to provide high-quality clinical research with a strong emphasis on patient safety and scientific integrity, which has been registered with the Egyptian Supreme Council of Clinical Research Ethics to conduct Phase I, II, and III clinical trials.

Key Features:
📌 64-Bed Capacity – Comfortable, well-equipped inpatient beds for long- and short-term clinical studies
📌 ICU Integration – Dedicated Intensive Care Unit (ICU) support ensures advanced monitoring and rapid response capabilities
📌 Institutional Review Board (IRB) Oversight – Fully compliant with ethical standards, backed by an IRB for every protocol, which has been registered with the Egyptian Supreme Council of Clinical Research Ethics
📌 Advanced Infrastructure – Modern labs, data systems, and dedicated pharmacy support
📌 Multidisciplinary Team – Experienced physicians, research nurses, and coordinators

📍 Whether you're a sponsor, CRO, or investigator, our facility is built to handle Phase I-IV trials with precision and care.

🔗 Let’s partner to bring the next generation of therapies to life.
Please contact us on info.research@marc-eg.org

20/07/2025

Today, we honor the enduring legacy of Professor Samira Ezzat, a leader whose kindness, assertiveness, and dedication left an indelible mark on all who knew her. She fostered a collaborative environment, making everyone feel like part of a family united by a shared vision.
May Allah have mercy on her soul and grant her Jannah

14/07/2025

MARC joined forces with our sister company, EVA Pharma, through signing an MOU between EVA Group and Porton Advanced Solutions, China. The aim: expanding CAR T-cell therapy research and access in the Middle East and Africa.

At MARC, we innovate with purpose, responding to unmet health needs by translating research into accessible healthcare solutions to save and improve lives.

As cancer immunotherapy is one of our three key health areas, we are on a mission to implement CAR T-cell therapy while staying true to our purpose: making novel solutions more accessible, even when the science is advanced and the costs are high. We are keen to both conduct innovative CAR T-cell research and support local and regional hospitals and industries in producing already-approved CAR-based therapies.